Sprites
Mein FinanzNachrichtenJetzt AnmeldenPasswort vergessen?
Montag, 28.05.2012Börsentäglich über 11.000 News von 416 internationalen Medien
Erweiterte
Suche
Ad hoc-Mitteilungen

ENTREMED INC

WKN: A1C07N  ISIN: US29382F2020  Ticker-Symbol: ENMN 
Aktie:
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
ENTREMED INC Chart 1 Jahr
1-Woche-Intraday-Chart
ENTREMED INC 1-Woche-Intraday-Chart

Aktuelle News zur ENTREMED Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache:
LeserMedien
15.05. 5
ROCKVILLE, Md., May 15, 2012 /PRNewswire/ --EntreMed, Inc. (NASDAQ: ENMD), a clinical-stage pharmaceutical company, today reported financial results for the three months ended March 31, 2012. (Logo:...
Mehr lesen zu:
EntreMed Reports First Quarter 2012 Financial Results
10.05. 13
ROCKVILLE, Md., May 10, 2012 /PRNewswire/ --EntreMed, Inc. (Nasdaq: ENMD), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, announced today that it has...
Mehr lesen zu:
EntreMed Regains Nasdaq Compliance With Shareholders' Equity Listing Requirement
03.04. 47
WASHINGTON (dpa-AFX) - Clinical-stage pharmaceutical company EntreMed Inc (ENMD) Tuesday announced that Dr Ken K Ren has been appointed as the Interim Chief Executive Officer of the company...
Mehr lesen zu:
Dr Ken Ren Appointed As Interim CEO Of EntreMed
03.04. 18
ROCKVILLE, Md., April 3, 2012 /PRNewswire/ -- EntreMed, Inc. (Nasdaq: ENMD), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, announced today that the Company...
Mehr lesen zu:
EntreMed Appoints Interim CEO
09.03. 2
09.03. 24
ROCKVILLE, Md., March 9, 2012 /PRNewswire/ -- EntreMed, Inc. (Nasdaq: ENMD), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, today reported results for...
Mehr lesen zu:
EntreMed Reports Fourth Quarter and Year-End 2011 Financial Results
05.03. 23
ROCKVILLE, Md., March 5, 2012 /PRNewswire/ --EntreMed, Inc. (Nasdaq: ENMD), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, announced today that it has...
Mehr lesen zu:
EntreMed Initiates Plans for China Office
06.02. 3
06.02. 12
ROCKVILLE, Md., Feb. 6, 2012 /PRNewswire/ --EntreMed, Inc. (Nasdaq: ENMD), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, announced today...
Mehr lesen zu:
EntreMed Completes Strategic Financing
06.02. 9
ROCKVILLE, Md., Feb. 6, 2012 /PRNewswire/ --EntreMed, Inc. (Nasdaq: ENMD), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, announced today that Wei-Wu...
Mehr lesen zu:
Biotech Leaders Wei-Wu He, Ph.D and Tak W. Mak, Ph.D Join EntreMed's Board of Directors
23.01. 4
23.01. 22
ROCKVILLE, Md., Jan. 23, 2012 /PRNewswire/ -- EntreMed, Inc. (Nasdaq: ENMD), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, announced today that it has...
Mehr lesen zu:
EntreMed Secures $10 Million Strategic Financing
12 Nachrichten in den letzten 6 Monaten